1.Congenital heart disease in Papu New Guinean children.
Papua New Guinea medical journal 1974;17(3):278-281
2.Analysis of survival and prognostic factors in extremely preterm infants.
Yin-Zhu CUI ; Qian-Shen ZHANG ; Hong-Yun HE ; Chun CHEN
Chinese Journal of Contemporary Pediatrics 2014;16(6):596-600
OBJECTIVETo investigate the survival rate, complications during hospitalization, and prognostic factors in extremely preterm infants (gestational age less than 28 weeks) in the neonatal intensive care unit (NICU).
METHODSA retrospective analysis was performed on 90 extremely preterm infants who were admitted to the NICU between January 2011 and March 2013 to investigate the perinatal data, delivery and resuscitation, ventilation/oxygen supply during hospitalization, mortality, and the incidence of severe (grade III/IV) intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), patent ductus arteriosus (PDA), and septicemia.
RESULTSAmong the 90 extremely preterm infants, the gestational age, birth weight, overall survival rate, mortality, and withdrawal rate were 26±1 weeks, 898±165 g, 57%, 9%, and 34%, respectively. The incidence rates of neonatal respiratory distress syndrome, BPD, PDA, ROP, and grade III/IV IVH were 88%, 85%, 69%, 68%, and 31%, respectively. The surviving infants had a mean length of hospital stay of 83±18 days and a mean weight at discharge of 2 419±300 g. The multivariate logistic regression analysis showed that grade III/IV IVH and pulmonary hemorrhage were high-risk factors for death or withdrawal, while antenatal corticosteroids were the protective factor for outcome (P<0.05).
CONCLUSIONSThe survival rate of extremely preterm infants is still much lower than that in developed countries. grade III/IV IVH, and pulmonary hemorrhage are important prognostic factors.
Bronchopulmonary Dysplasia ; epidemiology ; Ductus Arteriosus, Patent ; epidemiology ; Female ; Humans ; Infant Mortality ; Infant, Extremely Premature ; Infant, Newborn ; Logistic Models ; Male ; Prognosis ; Respiratory Distress Syndrome, Newborn ; epidemiology ; Retinopathy of Prematurity ; epidemiology ; Retrospective Studies ; Survival Rate
3.Assessment of risk factors for bronchopulmonary dysplasia with pulmonary hypertension and construction of a prediction nomogram model.
Shu Zhen DAI ; Shu Shu LI ; Mei Yun ZHOU ; Yan XU ; Lin ZHANG ; Yu Han ZHANG ; Dan Ni YE ; Li Ping XU ; Shu Ping HAN
Chinese Journal of Pediatrics 2023;61(10):902-909
Objective: To explore the risk factors of pulmonary hypertension (PH) in premature infants with bronchopulmonary dysplasia (BPD), and to establish a prediction model for early PH. Methods: This was a retrospective cohort study. Data of 777 BPD preterm infants with the gestational age of <32 weeks were collected from 7 collaborative units of the Su Xinyun Neonatal Perinatal Collaboration Network platform in Jiangsu Province from January 2019 to December 2022. The subjects were randomly divided into a training cohort and a validation cohort at a ratio of 8∶2 by computer, and non-parametric test or χ2 test was used to examine the differences between the two retrospective cohorts. Univariate Logistic regression and multivariate logistic regression analyses were used in the training cohort to screen the risk factors affecting the PH associated with BPD. A nomogram model was constructed based on the severity of BPD and its risk factors,which was internally validated by the Bootstrap method. Finally, the differential, calibration and clinical applicability of the prediction model were evaluated using the training and verification queues. Results: A total of 130 among the 777 preterm infants with BPD had PH, with an incidence of 16.7%, and the gestational age was 28.7 (27.7, 30.0) weeks, including 454 males (58.4%) and 323 females (41.6%). There were 622 preterm infants in the training cohort, including 105 preterm infants in the PH group. A total of 155 patients were enrolled in the verification cohort, including 25 patients in the PH group. Multivariate Logistic regression analysis revealed that low 5 min Apgar score (OR=0.87, 95%CI 0.76-0.99), cesarean section (OR=1.97, 95%CI 1.13-3.43), small for gestational age (OR=9.30, 95%CI 4.30-20.13), hemodynamically significant patent ductus arteriosus (hsPDA) (OR=4.49, 95%CI 2.58-7.80), late-onset sepsis (LOS) (OR=3.52, 95%CI 1.94-6.38), and ventilator-associated pneumonia (VAP) (OR=8.67, 95%CI 3.98-18.91) were all independent risk factors for PH (all P<0.05). The independent risk factors and the severity of BPD were combined to construct a nomogram map model. The area under the receiver operating characteristic (ROC) curve of the nomogram model in the training cohort and the validation cohort were 0.83 (95%CI 0.79-0.88) and 0.87 (95%CI 0.79-0.95), respectively, and the calibration curve was close to the ideal diagonal. Conclusions: Risk of PH with BPD increases in preterm infants with low 5 minute Apgar score, cesarean section, small for gestational age, hamodynamically significant patent ductus arteriosus, late-onset sepsis, and ventilator-associated pneumonia. This nomogram model serves as a useful tool for predicting the risk of PH with BPD in premature infants, which may facilitate individualized early intervention.
Infant
;
Male
;
Infant, Newborn
;
Humans
;
Pregnancy
;
Female
;
Bronchopulmonary Dysplasia/epidemiology*
;
Infant, Premature
;
Hypertension, Pulmonary/epidemiology*
;
Retrospective Studies
;
Nomograms
;
Ductus Arteriosus, Patent/epidemiology*
;
Pneumonia, Ventilator-Associated/complications*
;
Cesarean Section/adverse effects*
;
Gestational Age
;
Risk Factors
;
Sepsis
4.Treatment and prognosis of pulmonary hemorrhage in preterm infants during 2007-2016.
Chinese Journal of Contemporary Pediatrics 2018;20(4):255-260
OBJECTIVETo study the treatment and prognosis of pulmonary hemorrhage in preterm infants.
METHODSA total of 106 preterm infants diagnosed with pulmonary hemorrhage, who were hospitalized in the neonatal ward of Peking University Third Hospital between 2007 and 2016, were enrolled. These patients were divided into 2007-2011 group (34 cases) and 2012-2016 group (72 cases) according to the time of hospitalization, divided into conventional-frequency ventilation group (43 cases) and high-frequency oscillatory ventilation (HFOV) group (63 cases) according to the respiratory support method used after the development of pulmonary hemorrhage, and divided into non-operation group (34 cases) and operation group (14 cases) according to whether PDA ligation was performed for the unclosed PDA before pulmonary hemorrhage. The general data, treatment, and prognosis were compared between different groups.
RESULTSCompared with the 2007-2011 group, the 2012-2016 group had higher rates of HFOV and PDA ligation (P<0.05), a lower mortality rate during hospitalization (P<0.05), a longer length of hospital stay (P<0.05), and higher incidence rates of intracranial hemorrhage and bronchopulmonary dysplasia (P<0.05). Compared with the conventional-frequency ventilation group, the HFOV group had a lower mortality rate during hospitalization (P<0.05), a longer length of hospital stay (P<0.05), and higher incidence rates of intracranial hemorrhage and bronchopulmonary dysplasia (P<0.05). Compared with the non-operation group, the operation group had a lower mortality rate during hospitalization (P<0.05), a longer length of hospital stay (P<0.05), and higher incidence rates of intracranial hemorrhage and bronchopulmonary dysplasia (P<0.05).
CONCLUSIONSThe application of HFOV and PDA ligation can improve the survival rate of preterm infants with pulmonary hemorrhage, but the incidence of intracranial hemorrhage and bronchopulmonary dysplasia is also increased.
Bronchopulmonary Dysplasia ; epidemiology ; Cerebral Hemorrhage ; epidemiology ; Ductus Arteriosus, Patent ; surgery ; Hemorrhage ; mortality ; therapy ; High-Frequency Ventilation ; Humans ; Infant, Newborn ; Infant, Premature ; Length of Stay ; Ligation ; Lung Diseases ; mortality ; therapy ; Prognosis ; Time Factors
5.The Timing of Surgical Ligation for Patent Ductus Arteriosus Is Associated with Neonatal Morbidity in Extremely Preterm Infants Born at 23-25 Weeks of Gestation.
Se In SUNG ; Soo Young CHOI ; Jae Hyun PARK ; Myung Sook LEE ; Hye Soo YOO ; So Yoon AHN ; Yun Sil CHANG ; Won Soon PARK
Journal of Korean Medical Science 2014;29(4):581-586
The purpose of this study was to evaluate prognostic factors associated with surgical ligation for patent ductus arteriosus (PDA) in extremely preterm infants born at the limits of viability. Ninety infants who were born at 23-25 weeks of gestation and who received surgical ligation were included and their cases were retrospectively reviewed. Infants were classified into two different groups: survivors with no major morbidity (N), and non-survivors or survivors with any major morbidity (M). Clinical characteristics were compared between the groups. Possible prognostic factors were derived from this comparison and further tested by logistic regression analysis. The mean gestational age and the mean birth weight of M were significantly lower than those of N. Notably, the mean postnatal age at time of ligation in N was significantly later than that of the other group (17+/-12 vs 11+/-8 days in N and M, respectively). An adjusted analysis showed that delayed ligation (>2 weeks) was uniquely associated with a significantly decreased risk for mortality or composite morbidity after surgical ligation (OR, 0.105; 95% CI, 0.012-0.928). In conclusion, delayed surgical ligation for PDA (>2 weeks) is associated with decreased mortality or morbidities in extremely preterm infants born at 23-25 weeks of gestation.
Adult
;
Birth Weight
;
Demography
;
Ductus Arteriosus, Patent/diagnosis/epidemiology/*surgery
;
Female
;
Gestational Age
;
Humans
;
Infant, Extremely Premature
;
Infant, Newborn
;
Logistic Models
;
Male
;
Odds Ratio
;
Prognosis
;
Retrospective Studies
;
Time Factors
6.Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Saed Hossein FAKHRAEE ; Zohreh BADIEE ; Saied MOJTAHEDZADEH ; Mohammad KAZEMIAN ; Roya KELISHADI
Chinese Journal of Contemporary Pediatrics 2007;9(5):399-403
OBJECTIVEIntravenous indomethacin is the conventional treatment for patent ductus arteriosus (PDA) in preterm infants; however its use is associated with various side effects such as oliguria, gastrointestinal bleeding and reduction of cerebral perfusion. Intravenous ibuprofen has recently been used to treat PDA in preterm infants without reducing cerebral blood flow or affecting intestinal or renal hemodynamics. Intravenous forms of indomethacin and ibuprofen are not available in Iran. This study aimed to examine and compare the efficacy and safety of oral ibuprofen and oral indomethacin for the treatment of PDA in preterm infants.
METHODSThirty-six infants (gestational age less than 34 weeks) who had echocardiographically confirmed PDA were enrolled in this study. The patients were randomly administered with three oral doses of either indomethacin (0.2 mg/kg, at an interval of 24 hrs) or ibuprofen (a first dose of 10 mg/kg, followed at an interval of 24 hrs by two doses of 5 mg/kg each) (n=18 each group). The rate of ductal closure, side effects, complications, and the infants' clinical course were recorded.
RESULTSThe ductus was closed in all of 18 patients (100%) in the ibuprofen group and in 15 (83.3%) patients in the indomethacin group (P > 0.05). There were no significant differences in the levels of serum blood urea nitrogen and creatinine between the two groups before and after treatment. Necrotizing enterocolitis (NEC) occurred in 3 patients in the indomethacin group and none in the ibuprofen group (P < 0.05). The survival rate at 1 month after treatment was 94% (17/18) in both groups. One infant in the ibuprofen group died from sepsis and one in the indomethacin group died as a result of NEC.
CONCLUSIONSOral ibuprofen is as effective as oral indomethacin for the treatment of PDA in preterm infants. Oral ibuprofen therapy is associated with a lower incidence of NEC.
Administration, Oral ; Ductus Arteriosus, Patent ; drug therapy ; Enterocolitis, Necrotizing ; epidemiology ; Humans ; Ibuprofen ; administration & dosage ; adverse effects ; therapeutic use ; Indomethacin ; administration & dosage ; adverse effects ; therapeutic use ; Infant, Newborn ; Infant, Premature
7.Transcatheter closure of patent ductus arteriosus with the new Amplatzer Duct OccluderII.
Wei JI ; Fen LI ; Wei GAO ; Zhi-qing YU ; Mei-rong HUANG ; Li-jun FU ; Ying GUO ; Peng-jun ZHAO ; Ting-liang LIU ; Yu-qi ZHANG ; Yi-wei CHEN
Chinese Journal of Pediatrics 2013;51(2):126-129
OBJECTIVETo evaluate the indications, methodology and results of the transcatheter closure of patent ductus arteriosus (PDA) with the new Amplatzer Duct Occluder II (ADO-II).
METHODTotally 51 patients underwent transcatheter closure of PDA with the new ADO-II. The devices were delivered by 4F or 5F sheath through arterial or venous side respectively. The descending aorta angiography and transthoracic echocardiography was performed to evaluate the device position, residual shunt and complications caused by the device during and after implantation.
RESULTForty-nine patients had successful transcatheter closure of the PDA without significant residual shunts and artery obstruction during the short-term follow-up. One patient received the ADO-II dislodgment and first generation ADO re-implantation for the obvious descending aortal obstruction caused by ADO-II. Another patient had the ADO-II dislodgment and left pulmonary artery shaping surgery, because the ADO-II implantation led to obstruction of the left pulmonary artery. Both the obstructions in these two patients were ameliorated afterwards.
CONCLUSIONThe transcatheter closure using the ADO-II is safe and effective for the non-window type PDA with a small size.
Adolescent ; Aortography ; Cardiac Catheterization ; instrumentation ; methods ; Child ; Child, Preschool ; Ductus Arteriosus, Patent ; diagnostic imaging ; surgery ; Echocardiography, Doppler ; methods ; Female ; Follow-Up Studies ; Humans ; Infant ; Male ; Prosthesis Design ; Pulmonary Embolism ; epidemiology ; etiology ; surgery ; Reoperation ; Septal Occluder Device ; Treatment Outcome
8.Prevalence of Birth Defects in Korean Livebirths, 2005-2006.
Min A KIM ; Nan Hee YEE ; Jeong Soo CHOI ; Jung Yun CHOI ; Kyung SEO
Journal of Korean Medical Science 2012;27(10):1233-1240
We investigated the livebirths prevalence and occurrence pattern of birth defects in Korea. After the survey on birth defects was done in 2,348 medical institutions around the nation, the birth defect prevalence of livebirths in 2005-2006 was calculated. This study was based on the medical insurance claims database of the National Health Insurance Corporation. The number of livebirths in Korea was 883,184 from 2005-2006, and 25,335 cases of birth defects were notified to our study, equivalent to a prevalence of 286.9 per 10,000 livebirths. Anomalies of the circulatory system were the most common defects, accounting for 43.4% of birth defects with a prevalence of 124.5 per 10,000 livebirths. It was followed by the musculoskeletal system anomalies, the digestive system anomalies, and the urinary system anomalies. The five major birth defects based on the ranking of prevalence were atrial septal defect, ventricular septal defect, hydronephrosis, patent ductus arteriosus, and cleft lip/palate. Birth defects in livebirths were associated with a high proportion of low birthweight, prematurity, multiple births and advanced maternal age. The prevalence of birth defects in Korea is similar to or lower than those reported in developed countries. Our study suggests baseline data to explain the current status of birth defects and to establish a registry system of birth defects in Korea.
Adult
;
Asian Continental Ancestry Group
;
Cleft Lip/epidemiology
;
Cleft Palate/epidemiology
;
Congenital Abnormalities/*epidemiology
;
Databases, Factual
;
Ductus Arteriosus, Patent/epidemiology
;
Female
;
Gestational Age
;
Heart Septal Defects, Atrial/epidemiology
;
Heart Septal Defects, Ventricular/epidemiology
;
Humans
;
Hydronephrosis/epidemiology
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Infant, Premature
;
Live Birth
;
Male
;
Maternal Age
;
Musculoskeletal Abnormalities/epidemiology
;
Pregnancy
;
Prevalence
;
Republic of Korea/epidemiology
9.Prevalence of Congenital Heart Defects Associated with Down Syndrome in Korea.
Min A KIM ; You Sun LEE ; Nan Hee YEE ; Jeong Soo CHOI ; Jung Yun CHOI ; Kyung SEO
Journal of Korean Medical Science 2014;29(11):1544-1549
Congenital heart defect (CHD) is common in infants with Down syndrome (DS), which is the principle cause of mortality. However, there is no data available for the frequency and types of CHD in infants with DS in Korea. We investigated the frequency of CHD in infants with DS in Korea. After the survey on birth defects was conducted throughout the country, the prevalence of CHD in DS in 2005-2006 was calculated. This study was conducted based on the medical insurance claims database of the National Health Insurance Corporation. The number of total births in Korea was 888,263 in 2005-2006; of them, 25,975 cases of birth defects were identified. The prevalence of DS was 4.4 per 10,000 total births, accounting for 1.5% of all birth defects. Of the 394 infants with DS, 224 (56.9%) had a CHD. Atrial septal defect was the most common defect accounting for 30.5% of DS followed by ventricular septal defect (19.3%), patent duct arteriosus (17.5%), and atrioventricular septal defect (9.4%). Our study will be helpful to demonstrate the current status of DS and to identify the distribution of CHD in infants with DS in Korea.
Adult
;
Asian Continental Ancestry Group
;
Birth Weight
;
Chromosome Aberrations
;
Databases, Factual
;
Down Syndrome/*complications
;
Ductus Arteriosus, Patent/epidemiology
;
Female
;
Gestational Age
;
Heart Defects, Congenital/*epidemiology/etiology
;
Heart Septal Defects/epidemiology
;
Heart Septal Defects, Atrial/epidemiology
;
Heart Septal Defects, Ventricular/epidemiology
;
Humans
;
Male
;
Prevalence
;
Republic of Korea/epidemiology
10.Comparison of Outcomes and Costs of Transcatheter Therapeutic Intervention and Surgical Ligation for the Treatment of Patent Ductus Arteriosus.
Swee Chye QUEK ; Diana SANTOS ; Dimple Dayaram RAJGOR ; Fan YU ; Robert GRIGNANI
Annals of the Academy of Medicine, Singapore 2016;45(6):256-258
Adolescent
;
Cardiac Catheterization
;
economics
;
methods
;
Child
;
Child, Preschool
;
Ductus Arteriosus, Patent
;
surgery
;
Female
;
Health Care Costs
;
Humans
;
Infant
;
Intensive Care Units
;
economics
;
utilization
;
Length of Stay
;
economics
;
statistics & numerical data
;
Ligation
;
economics
;
methods
;
Male
;
Postoperative Complications
;
economics
;
epidemiology
;
Retrospective Studies
;
Septal Occluder Device
;
economics
;
Singapore
;
epidemiology
;
Treatment Outcome